SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-10-190972
Filing Date
2010-08-17
Accepted
2010-08-17 11:08:39
Documents
6
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q AMENDMENT #1 d10qa.htm 10-Q/A 1986422
2 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 11444
3 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 11398
4 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 4116
5 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 4201
6 GRAPHIC g74605tx001.jpg GRAPHIC 7225
  Complete submission text file 0001193125-10-190972.txt   2029754
Mailing Address
Business Address 16825 NORTHCHASE DR STE 1300 HOUSTON TX 77060 2818732674
US ONCOLOGY INC (Filer) CIK: 0000943061 (see all company filings)

IRS No.: 841213501 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-26190 | Film No.: 101022147
SIC: 8093 Services-Specialty Outpatient Facilities, NEC

Mailing Address 16825 NORTHCHASE DRIVE, SUITE 1300 HOUSTON TX 77060
Business Address 16825 NORTHCHASE DRIVE, SUITE 1300 HOUSTON TX 77060 (832) 601-8766
US Oncology Holdings, Inc. (Filer) CIK: 0001333191 (see all company filings)

IRS No.: 200873619 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 333-126922 | Film No.: 101022146
SIC: 8060 Services-Hospitals